However, conflicting evidence regarding ERβ’s role in cancer arises from patient variability, tissue heterogeneity, and weak correlations between ERβ mRNA and protein levels, highlighting the need for further research to better elucidate its function in cancer as well [51]. Here, ESR2 is linked to cancer.